Pathway nets another patent for atherectomy system

Pathway Medical Technologies, a provider of endovascular treatments for peripheral arterial disease (PAD), was recently granted another patent for its Pathway PV atherectomy system.

The issuance of this latest patent enhances the intellectual property related to Pathway’s atherectomy system, which is designed to treat the arterial disease found in the legs, according to the company.

The Kirkland, Wash.-based Pathway has a total of three patents issued by the U.S. patent office relating to differential cutting and the removal of atherosclerotic plaque for its rotational atherectomy system with several other patents pending.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.